Funding Available for WAS Research for 2021-2023

The Wiskott-Aldrich Foundation (WAF) is announcing a call for research proposals to be granted in 2021-2023. WAF will grant seed money funding for a total of $100,000 for one proposal or for two proposals for $50,000 each.

Areas of Interest:

• New and innovative curative treatment approaches for X‐linked thrombocytopenia (XLT)/Wiskott‐Aldrich Syndrome (WAS) with reduced mortality and morbidity.
• Innovative methods to better existent curative treatments leading to less mortality, morbidity, and or improved correction of the disease.

Application Deadline: September 30, 2020

More Information

Letter of Intent Form